Improved methods and compositions for safe and effective treatment of telangiectasia

Details for Australian Patent Application No. 2011231544 (hide)

Owner GALDERMA RESEARCH & DEVELOPMENT

Inventors Graeber, Michael; Loesche, Christian; Freidenreich, Philip; Liu, Yin; Leoni, Matthew James

Agent Griffith Hack

Pub. Number AU-A-2011231544

PCT Pub. Number WO2011/117378

Priority 61/282,753 26.03.10 US

Filing date 25 March 2011

Wipo publication date 29 September 2011

International Classifications

A61K 31/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 9/00 Medicinal preparations characterised by special physical form

A61K 9/06 Medicinal preparations characterised by special physical form - Ointments

A61P 17/00 Drugs for dermatological disorders

Event Publications

27 September 2012 PCT application entered the National Phase

  PCT publication WO2011/117378 Priority application(s): WO2011/117378

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011231546-Preparation of hydrated polymorphs of 4-amino-5-fluoro-3-[6-(4methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salt

2011231543-Improved methods and compositions for safe and effective treatment of erythema